Valuation: Agilent Technologies, Inc.

Market Cap 39.47B 34.66B 32.24B 29.58B 55.58B 3,801B 56.44B 383B 150B 1,869B 148B 145B 6,461B P/E 2026 *
27.2x
P/E 2027 * 23.8x
Enterprise Value 40.27B 35.37B 32.9B 30.19B 56.72B 3,878B 57.59B 391B 153B 1,907B 151B 148B 6,593B EV / Sales 2026 *
5.41x
EV / Sales 2027 * 4.94x
Free-Float
99.81%
Yield 2026 *
0.73%
Yield 2027 * 0.79%
07-23 Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers MT
07-21 Danaher's revenue outlook cut, biotech miss overshadow profit forecast lift RE
07-20 HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited CI
07-14 Agilent Technologies Receives Fda Approval for Pd-L1 Ihc 28-8 Pharmdx in Esophageal Squamous Cell Carcinoma, Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma CI
07-14 Agilent Wins FDA Approval for PD-L1 Test to Guide Bristol Myers' Opdivo Use in GI Cancers MT
07-13 Baird Adjusts Agilent Technologies Price Target to $160 From $158, Maintains Outperform Rating MT
07-08 Agilent Technologies Inc. Expands Altura Portfolio with Inert Size Exclusion and Plrp-S Columns for Biotherapeutic Analysis CI
07-06 Evercore ISI Adjusts Agilent Technologies PT to $148 From $144 MT
07-01 Agilent Technologies Launches Xcelligence RTCA Esight AI Module CI
06-26 Analyst recommendations: Crocs, Dell, On Semiconductor, Qualcomm, Micron… Zonebourse
06-25 Agilent Technologies, Inc. Closes $600 Million Private Placement Of 4.900% Senior Notes Due 2032 CI
06-25 Agilent Technologies, Inc. (NYSE:A) completed the acquisition of Biocare Medical, LLC from an investor group led by Excellere Capital Fund III LP, a fund managed by Excellere Capital Management LLC and GHO Capital Partners LLP. CI
06-25 Agilent Technologies Completes Purchase of Biocare Medical From Excellere-Led Investor Group MT
1 day-0.93%
1 week+5.41%
Current month+4.32%
1 month+5.27%
3 months+19.92%
6 months+2.15%
Current year+1.84%
1 week 125
Extreme 125
141.95
1 month 125
Extreme 125
141.95
Current year 108.35
Extreme 108.35
150.1
1 year 108.35
Extreme 108.35
160.27
3 years 96.43
Extreme 96.43
160.27
5 years 96.43
Extreme 96.43
179.57
10 years 42.92
Extreme 42.92
179.57
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-20
Director of Finance/CFO 49 2025-11-16
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Chairman 75 2017-03-15
Director/Board Member 78 2010-12-31
Director/Board Member 72 2015-06-30
Date Insider Type Main position Quantity % Market Cap.
6/26/26 Tax

Executive/Senior Manager

-30 0.0000%
6/3/26 Tax

Chief Executive Officer

-418 0.0001%
6/2/26 Other

Controller/Auditor

8,872 0.0031%
Change 5-day change 1-year change 3-year change Capi.($)
-0.89%+5.41%+15.14%+8.50% 39.47B
-1.46%+5.90%+18.71%-1.33% 213B
-0.81%-6.31%-5.84%-25.97% 135B
+1.83%-2.07%-30.77%+4.54% 117B
+2.05%+1.03%-58.12%-14.73% 64.78B
-0.64%-3.01%+9.70%-9.03% 48.26B
+3.03%-0.17%-26.81%-31.58% 43.08B
-2.15%+1.90%+25.97%+31.02% 37.55B
-0.90%+4.82%+81.76%+4.03% 29.78B
-1.02%-3.01%-20.32%-24.13% 28.2B
Average -0.18%-3.60%+0.94%-5.87% 75.64B
Weighted average by Cap. -0.25%-4.93%-1.90%-6.71%

Financials

2026 *2027 *
Net sales 7.45B 6.54B 6.08B 5.58B 10.49B 717B 10.65B 72.24B 28.23B 353B 27.96B 27.36B 1,219B 7.9B 6.94B 6.45B 5.92B 11.13B 761B 11.3B 76.63B 29.94B 374B 29.66B 29.02B 1,293B
Net income 1.47B 1.29B 1.2B 1.1B 2.06B 141B 2.1B 14.21B 5.55B 69.39B 5.5B 5.38B 240B 1.63B 1.44B 1.34B 1.23B 2.3B 157B 2.34B 15.85B 6.19B 77.39B 6.14B 6B 268B
Net Debt 807M 709M 659M 605M 1.14B 77.74B 1.15B 7.83B 3.06B 38.22B 3.03B 2.97B 132B -401M -352M -328M -301M -565M -38.63B -574M -3.89B -1.52B -18.99B -1.51B -1.47B -65.66B
Logo Agilent Technologies, Inc.
Agilent Technologies, Inc. specializes in the design, manufacturing and marketing of measurement instruments intended primarily for the communications, electronics, life sciences, and chemistry sectors. The activity is organized mainly around three families of products: - electronic measurement instruments; - bio-analytical measurement instruments: used to identify, quantify, and analyze the physical and biological properties of substances and products; - measurement instruments for semiconductors. Net sales break down by source of income between sales of products (71.2%) and services (28.8%). Net sales are distributed geographically as follows: the United States (33.7%), China and Hong Kong (17.6%) and other (48.7%).
Employees
18,000
Date Price Change Volume
26-07-24 US$138.56 -0.85% 689,025
26-07-23 US$139.74 +4.71% 2,935,856
26-07-22 US$133.46 +0.45% 2,662,820
26-07-21 US$132.86 +2.00% 2,383,954
26-07-20 US$130.26 -0.91% 2,470,803
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
139.74USD
Average target price
159.32USD
Spread / Average Target
+14.01%

Quarterly revenue - Rate of surprise